Japan Drug Discovery Outsourcing Market Size & Outlook
Japan drug discovery outsourcing market, 2018-2030 (US$M)
Related Markets
Japan drug discovery outsourcing market highlights
- The Japan drug discovery outsourcing market generated a revenue of USD 351.4 million in 2022 and is expected to reach USD 659.8 million by 2030.
- The Japan market is expected to grow at a CAGR of 8.2% from 2023 to 2030.
- In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2022.
- Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
Drug discovery outsourcing market data book summary
| Market revenue in 2022 | USD 351.4 million |
| Market revenue in 2030 | USD 659.8 million |
| Growth rate | 8.2% (CAGR from 2022 to 2030) |
| Largest segment | Lead identification & candidate optimization |
| Fastest growing segment | Other Associated Workflow |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
| Key market players worldwide | Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex |
Other key industry trends
- In terms of revenue, Japan accounted for 9.9% of the global drug discovery outsourcing market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan drug discovery outsourcing market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 506.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Discovery Outsourcing Market Scope
Drug Discovery Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan drug discovery outsourcing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery outsourcing market will help companies and investors design strategic landscapes.
Lead identification & candidate optimization was the largest segment with a revenue share of 32.5% in 2022. Horizon Databook has segmented the Japan drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has one of the fastest aging population in the world and is developing a demographic trend that results in higher incidence of cancer. This makes Japan a lucrative market for drug discovery outsourcing.
Furthermore, revised Pharmaceutical Affairs Law supports research activities regarding tissue diagnostics and cancer in Japan, which is expected to increase the market growth in this country in the near future in 2015, Japan Agency for Medical Research and Development (AMED) was established with an objective to manage data related to investigations and clinical trials, improve R&D infrastructure, and promote international strategies.
This agency is just one example of the initiatives taken to boost the drug discovery market in Japan. In April 2017, Japan-based company — PeptiDream entered into a multitarget discovery and optimization collaboration with Janssen Pharmaceuticals.
Reasons to subscribe to Japan drug discovery outsourcing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan drug discovery outsourcing market databook
-
Our clientele includes a mix of drug discovery outsourcing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan drug discovery outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Japan drug discovery outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan drug discovery outsourcing market outlook size, by workflow, 2018-2030 (US$M)
Japan Drug Discovery Outsourcing Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
